Pan-Antagonists for the Androgen Receptor and Androgen Receptor Mutants Associated with Anti-Androgen Withdrawal
Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.
Patents:US 20,090,270,512
Inventor(s):
KOH JOHN TZE-TZUN [US]; MCGINLEY PAULA LYNN [US]; PAN HONGMU [US]
Type of Offer:
Sale
« More Medical Patents